Table 4. Funding of the UK oncology research papers in 1999–2001, grouped by RL (integer counts); mean annual totals.
RL: ONCOL | N(A) | % of A | GOV | GOV, % | PNP | PNP, % | CRUK | CRUK, % |
---|---|---|---|---|---|---|---|---|
1–1.5 | 880 | 32 | 98 | 11 | 208 | 24 | 118 | 13 |
1.5–2 | 426 | 15 | 52 | 12 | 134 | 31 | 62 | 15 |
2–2.5 | 443 | 16 | 82 | 18 | 251 | 57 | 147 | 33 |
2.5–3 | 225 | 8 | 40 | 18 | 1247 | 55 | 55 | 24 |
3–3.5 | 330 | 12 | 77 | 23 | 189 | 57 | 99 | 30 |
3.5–4 | 452 | 16 | 163 | 36 | 300 | 66 | 163 | 36 |
Total | 2756 | 100 | 511 | 19 | 1205 | 44 | 644 | 23 |
RL: ONCOL | N(A) | % of A | Pharm | Pharm, % | Ind'y | Ind'y, % | None | None, % |
1–1.5 | 880 | 32 | 53 | 6 | 25 | 3 | 527 | 60 |
1.5–2 | 426 | 15 | 39 | 9 | 17 | 4 | 200 | 47 |
2–2.5 | 443 | 16 | 71 | 16 | 20 | 4 | 96 | 22 |
2.5–3 | 225 | 8 | 22 | 10 | 70 | 3 | 48 | 21 |
3–3.5 | 330 | 12 | 43 | 13 | 17 | 5 | 43 | 13 |
3.5–4 | 452 | 16 | 65 | 15 | 20 | 4 | 37 | 8 |
Total | 2756 | 100 | 294 | 11 | 106 | 4 | 950 | 35 |
A status=inspected papers; CRUK=Cancer Research UK; GOV=the UK government; Ind'y=other industry; Pharm=pharmaceutical industry; PNP=UK private nonprofit. Note: columns may not add correctly because of rounding.